Treatment with CDDP and VINC did not alter the immune content of 975A2 tumor (Supplementary Fig. S2), while, on the contrary DX, IRI, MTX and OXP were effective in recruiting different subsets of CD45+ immune cells at different times (Fig. 2D and E). This evidence concerns the gene PTPRC and neoplasm.